DIFLUCAN
Drug
PFIZER INC.
Total Payments
$58,232
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $58,232 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $58,232 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MONITORING AND EVALUATION OF A PUBLIC HEALTH PROGRAMME CRYPTOCOCCAL SCREENING AND TREATMENT IN SOUTH AFRICA | PFIZER INC. | $58,232 | 0 |
Top Doctors Receiving Payments for DIFLUCAN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Atlanta, GA | $58,232 | 1 |
Ad
Manufacturing Companies
- PFIZER INC. $58,232
Product Information
- Type Drug
- Total Payments $58,232
- Total Doctors 0
- Transactions 1
About DIFLUCAN
DIFLUCAN is a drug associated with $58,232 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INC..
Payment data is available from 2018 to 2018. In 2018, $58,232 was paid across 1 transactions to 0 doctors.
The most common payment nature for DIFLUCAN is "Unspecified" ($58,232, 100.0% of total).
DIFLUCAN is associated with 1 research study, including "MONITORING AND EVALUATION OF A PUBLIC HEALTH PROGRAMME CRYPTOCOCCAL SCREENING AND TREATMENT IN SOUTH AFRICA" ($58,232).